Your browser doesn't support javascript.
loading
Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain.
Kawazoe, Hitoshi; Sumikawa, Satomi; Nakauchi, Kana; Yakushijin, Yoshihiro; Yamamoto, Yuji; Watanabe, Yuji; Tanaka, Akihiro; Araki, Hiroaki.
Afiliação
  • Kawazoe H; Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan. hitoshik@m.ehime-u.ac.jp.
  • Sumikawa S; Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
  • Nakauchi K; Division of Nursing, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
  • Yakushijin Y; Cancer Center, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
  • Yamamoto Y; Division of Gastrointestinal Surgery and Surgical Oncology, Department of Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan.
  • Watanabe Y; Division of Gastrointestinal Surgery and Surgical Oncology, Department of Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan.
  • Tanaka A; Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
  • Araki H; Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
Int J Clin Pharm ; 39(6): 1291-1297, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29027645
ABSTRACT
Background Venous pain induced by peripheral intravenous administration of oxaliplatin remains clinically unresolved. Objective The aim of this study was to determine the efficacy of comprehensive intervention care for venous pain in colorectal cancer patients receiving oxaliplatin. Setting A Japanese tertiary hospital. Method We treated all outpatients after April 2012 with comprehensive intervention care including pre-warming of the oxaliplatin solution, use of a hot compress, and pH adjustment by combination with dexamethasone. We retrospectively reviewed the electronic medical records from colorectal cancer patients who had received oxaliplatin via a peripheral vein between December 2009 and June 2014. Main outcome measures The primary endpoint of this study was the incidence of venous pain at the administration site during oxaliplatin infusion, according to injection site reaction grade ≥ 2. Results We evaluated 271 treatment courses in 59 patients. Venous pain occurred in 42 courses (15.5%) among 26 patients. Multivariate logistic regression analysis revealed that female gender and body mass index ≥ 25 kg/m2 were significantly associated with an increased risk of venous pain during all courses (adjusted odds ratio [OR] 3.18, 95% confidence interval [CI] 1.35-7.92; P < 0.01; and adjusted OR 3.37, 95% CI 1.26-9.40; P = 0.02, respectively), whereas comprehensive intervention care were significantly associated with reduced risk of venous pain during all courses (adjusted OR 0.10, 95% CI 0.02-0.44; P < 0.01). Conclusion Comprehensive intervention care is a clinical treatment option for oxaliplatin-induced peripheral venous pain in patients with colorectal cancer, especially females with obesity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Dor / Manejo da Dor / Administração Intravenosa / Temperatura Alta / Concentração de Íons de Hidrogênio Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Int J Clin Pharm Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Dor / Manejo da Dor / Administração Intravenosa / Temperatura Alta / Concentração de Íons de Hidrogênio Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Int J Clin Pharm Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão